Last deal

$42M

Amount

Series D

Stage

25.07.2024

Date

7

all rounds

$115.1M

Total amount

General

About Company
Scopio Labs provides digital cell morphology imaging and AI solutions for hematology microscopy and diagnostics.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Scopio

founded date

01.01.2015

Number of employees

Company Type

For Profit

Last funding type

Series D

IPO status

Private

Description

The company's computational microscope and diagnostics platform offers fully digital diagnostic applications and imaging platforms that enhance clinical workflows. Scopio's solutions aim to showcase thousands of cells at scale in high resolution, enabling new hematology diagnostic methods. By assisting lab experts with fast, early, and accurate detection and diagnosis of disease, Scopio expedites patients' access to life-saving treatments.
Contacts